Sari Pesonen

1.9k total citations
33 papers, 1.1k citations indexed

About

Sari Pesonen is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Sari Pesonen has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 22 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Sari Pesonen's work include Virus-based gene therapy research (27 papers), CAR-T cell therapy research (19 papers) and Cancer Research and Treatments (12 papers). Sari Pesonen is often cited by papers focused on Virus-based gene therapy research (27 papers), CAR-T cell therapy research (19 papers) and Cancer Research and Treatments (12 papers). Sari Pesonen collaborates with scholars based in Finland, United States and Germany. Sari Pesonen's co-authors include Akseli Hemminki, Anna Kanerva, Vincenzo Cerullo, Iulia Diaconu, Gerd Bauerschmitz, Kilian Guse, Tuuli Ranki, Lotta Kangasniemi, Camilla Ribacka and André Lieber and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Sari Pesonen

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sari Pesonen Finland 20 700 659 537 219 125 33 1.1k
Gerd Bauerschmitz Germany 23 930 1.3× 1.3k 1.9× 1.0k 1.9× 287 1.3× 114 0.9× 55 1.6k
Lotta Kangasniemi Finland 16 685 1.0× 840 1.3× 542 1.0× 243 1.1× 145 1.2× 24 1.0k
Kenneth Rogulski United States 12 516 0.7× 785 1.2× 697 1.3× 244 1.1× 68 0.5× 13 1.1k
Lynette P. Steele United Kingdom 15 506 0.7× 613 0.9× 362 0.7× 166 0.8× 337 2.7× 19 1.0k
Sari Pesonen Finland 16 629 0.9× 734 1.1× 448 0.8× 206 0.9× 213 1.7× 24 947
Timo Joensuu Finland 18 668 1.0× 716 1.1× 367 0.7× 176 0.8× 190 1.5× 27 893
Zao-zhong Su United States 9 335 0.5× 336 0.5× 377 0.7× 105 0.5× 302 2.4× 9 802
A.G. Jochemsen Netherlands 15 356 0.5× 272 0.4× 683 1.3× 85 0.4× 63 0.5× 20 863
Mari Hirvinen Finland 13 550 0.8× 651 1.0× 361 0.7× 196 0.9× 236 1.9× 19 878
Riikka Havunen Finland 19 934 1.3× 753 1.1× 375 0.7× 223 1.0× 335 2.7× 44 1.1k

Countries citing papers authored by Sari Pesonen

Since Specialization
Citations

This map shows the geographic impact of Sari Pesonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari Pesonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari Pesonen more than expected).

Fields of papers citing papers by Sari Pesonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari Pesonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari Pesonen. The network helps show where Sari Pesonen may publish in the future.

Co-authorship network of co-authors of Sari Pesonen

This figure shows the co-authorship network connecting the top 25 collaborators of Sari Pesonen. A scholar is included among the top collaborators of Sari Pesonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari Pesonen. Sari Pesonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zamarin, Dmitriy & Sari Pesonen. (2015). Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data. Human Gene Therapy. 26(8). 538–549. 17 indexed citations
3.
Bramante, Simona, Anniina Koski, Ilkka Liikanen, et al.. (2015). Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer. OncoImmunology. 5(2). e1078057–e1078057. 36 indexed citations
4.
Knuuttila, Anna, Anja Kipar, Sari Pesonen, et al.. (2014). Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles. Molecular Therapy — Oncolytics. 1. 14002–14002. 12 indexed citations
5.
Pesonen, Sari, Iulia Diaconu, Lotta Kangasniemi, et al.. (2012). Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients. Cancer Research. 72(7). 1621–1631. 107 indexed citations
6.
Hemminki, Otto, Iulia Diaconu, Vincenzo Cerullo, et al.. (2012). Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer. Molecular Therapy. 20(9). 1821–1830. 62 indexed citations
7.
Koski, Anniina, Mari Raki, Petri Nokisalmi, et al.. (2011). Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer. Molecular Therapy. 20(1). 221–229. 28 indexed citations
8.
Liikanen, Ilkka, João D. Dias, Petri Nokisalmi, et al.. (2010). Adenoviral E4orf3 and E4orf6 Proteins, But Not E1B55K, Increase Killing of Cancer Cells by Radiotherapy in vivo. International Journal of Radiation Oncology*Biology*Physics. 78(4). 1201–1209. 3 indexed citations
9.
Pesonen, Sari, Heikki Helin, Petri Nokisalmi, et al.. (2010). Oncolytic adenovirus treatment of a patient with refractory neuroblastoma. Acta Oncologica. 49(1). 120–122. 26 indexed citations
10.
Diaconu, Iulia, Sari Pesonen, Anna Kanerva, et al.. (2010). Calcium Gluconate in Phosphate Buffered Saline Increases Gene Delivery with Adenovirus Type 5. PLoS ONE. 5(9). e13103–e13103. 1 indexed citations
11.
Hemminki, Otto, Gerd Bauerschmitz, Silvio Hemmi, et al.. (2010). Oncolytic adenovirus based on serotype 3. Cancer Gene Therapy. 18(4). 288–296. 47 indexed citations
12.
Rajecki, Maria, Mari Raki, Sophie Escutenaire, et al.. (2010). Safety of Glucocorticoids in Cancer Patients Treated with Oncolytic Adenoviruses. Molecular Pharmaceutics. 8(1). 93–103. 5 indexed citations
13.
Joensuu, Timo, Petri Nokisalmi, C.A. Reddy, et al.. (2009). A Phase I/II Trial of Gefitinib Given Concurrently With Radiotherapy in Patients With Nonmetastatic Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 78(1). 42–49. 22 indexed citations
14.
Dias, João D., Kilian Guse, Petri Nokisalmi, et al.. (2009). Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures. European Journal of Cancer. 46(3). 625–635. 25 indexed citations
15.
Koski, Anniina, Maria Rajecki, Kilian Guse, et al.. (2009). Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells. The Journal of Gene Medicine. 11(11). 966–977. 29 indexed citations
16.
Diaconu, Iulia, Laura Denby, Sari Pesonen, et al.. (2009). Serotype Chimeric and Fiber-Mutated Adenovirus Ad5/19p-HIT for Targeting Renal Cancer and Untargeting the Liver. Human Gene Therapy. 20(6). 611–620. 13 indexed citations
17.
Pesonen, Sari, Petri Nokisalmi, Ari Ristimäki, et al.. (2008). Treatment of cancer patients with capsid modified double controlled oncolytic adenovirus Ad5/3-Cox2L-D24. Cancer Research. 68. 2818–2818. 1 indexed citations
18.
Särkioja, Merja, Sari Pesonen, Mari Raki, et al.. (2008). Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies. Gene Therapy. 15(12). 921–929. 31 indexed citations
19.
Ribacka, Camilla, Sari Pesonen, & Akseli Hemminki. (2008). Cancer, stem cells, and oncolytic viruses. Annals of Medicine. 40(7). 496–505. 30 indexed citations
20.
Eriksson, Minna, Kilian Guse, Gerd Bauerschmitz, et al.. (2007). Oncolytic Adenoviruses Kill Breast Cancer Initiating CD44+CD24–/Low Cells. Molecular Therapy. 15(12). 2088–2093. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerd Bauerschmitz Breakdown of academic impact, for papers by Lotta Kangasniemi Breakdown of academic impact, for papers by Kenneth Rogulski Breakdown of academic impact, for papers by Lynette P. Steele Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Timo Joensuu Breakdown of academic impact, for papers by Zao-zhong Su Breakdown of academic impact, for papers by A.G. Jochemsen Breakdown of academic impact, for papers by Mari Hirvinen Breakdown of academic impact, for papers by Riikka Havunen
Rankless by CCL
2026